NASDAQ: ENTX - Entera Bio Ltd.

六个月盈利: -7.89%
股息率: 0.00%
部门: Healthcare

促销时间表 Entera Bio Ltd.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司 Entera Bio Ltd.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered peptide and protein therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures.

更多详情
Its other product candidate is GLP-2, which is in preclinical trial for the treatment of short bowl syndrome; and hGh for the GH deficiency. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

IPO date 2018-06-28
ISIN IL0011429839
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.enterabio.com
Цена ао 1.82
每日价格变化: -2.56% (1.796)
每周价格变化: -10.26% (1.95)
每月价格变化: -15.21% (2.064)
3个月内价格变化: -18.6% (2.15)
六个月内的价格变化: -7.89% (1.9)
每年价格变化: +4.79% (1.67)
3年内价格变化: -39.66% (2.9)
5年内价格变化: -44.27% (3.14)
年初以来价格变化: -19.72% (2.18)
所有参数

低估

姓名 意义 年级
P/S 1352.38 1
P/BV 1.82 8
P/E 2144.95 1
EV/EBITDA -0.9348 0
全部的: 4

效率

姓名 意义 年级
ROA, % -75.55 0
ROE, % -85.59 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0439 10
全部的: 9.6

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -94.07 0
盈利能力 Ebitda, % -21.39 0
盈利能力 EPS, % -65.78 0
全部的: 0
更多详情

机构 体积 分享, %
Knoll Capital Management, LLC 3881879 10.94
TWO SIGMA SECURITIES, LLC 69441 0.2
Renaissance Technologies, LLC 57400 0.16
Geode Capital Management, LLC 17597 0.05
PNC Financial Services Group, Inc. 13000 0.04
HighTower Advisors, LLC 11830 0.03
Millennium Management LLC 10097 0.03
Morgan Stanley 1000 0
Group One Trading, L.P. 345 0
Royal Bank of Canada 200 0



导师 职称 支付 出生年份
Ms. Miranda J. Toledano M.B.A. CEO & Director 418k 1977 (48 年)
Dr. Hillel Galitzer M.B.A., Ph.D. Chief Operating Officer 296k 1978 (47 年)
Ms. Dana Yaacov-Garbeli CPA Chief Financial Officer 193k 1983 (42 年)
Dr. Gregory Burshtein Ph.D. Chief of Research & Development 1976 (49 年)

地址: Israel, Jerusalem, Kiryat Hadassah Minrav Building - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.enterabio.com